APS

APS Virtual Poster Showcase · 2020

Concerns with and Support for Immunotherapy for Substance Use Disorder

Virtual · June 2020

Poster Sessions · Clinical Science

  • Kathryn Hodges
    Muhlenberg College
  • Meray Faragalla
    Muhlenberg College
  • Brittany Bashore
    Muhlenberg College
  • David Woodbury
    Muhlenberg College
  • Jeffrey Rudski
    Muhlenberg College

Abstract

Immunotherapy (IT) treatments are being developed for Substance Use Disorder (SUD). Participants believed such treatments are likely to be effective, but were concerned with diminished autonomy, increased overdose risk, and decreased efficacy of related medications (particularly for children). Support increased when considering IT for people with histories of SUD.

Addiction